Dr. Mojan Habibi, MD

Dr. Habibi practices at PIH Health Whittier Hospital in Whittier, California, part of PIH Health.

Dr. Habibi's NPI, 1326591322, was assigned on July 27, 2016. Dr. Habibi holds California license 158168.

Dr. Habibi's primary practice is PIH Health Whittier Hospital, at 12401 Washington Blvd, Whittier, CA 90602 in Los Angeles County. The practice phone is (562) 698-0811.

Dr. Habibi's primary practice is PIH Health Whittier Hospital in Whittier, California, part of PIH Health. Dr. Habibi is also affiliated with Cedars-Sinai Medical Center. The medical group on file is PIH Health Physicians. Dmand AI also links Dr. Habibi to 1 more hospital, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Habibi practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Habibi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Habibi's licenses on file in 2 states: California and Illinois.

CMS data shows 520 Medicare services from Dr. Habibi across 3 procedure codes in 2024, for 163 Medicare patients. Medicare paid $35,978 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 163 Medicare patients who saw Dr. Habibi in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 3.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Habibi's median patient age at 73, with 51% women.

In 2024, Dr. Habibi wrote 423 Medicare Part D claims for 159 patients. 91% of them were for generic drugs. CMS names the drug for 168 of them, across 10 drugs with 11 or more claims each, at $2,202 in total drug cost. In 2023, CMS named 191 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Habibi for performance year 2024, reported as part of a group. Dr. Habibi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Habibi from 4 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $28.